PUMC

PUMC Pharmaceutical Co., Ltd. is a specialized pharmaceutical company affiliated with the Institute of Materia Medica (IMM) of the Chinese Academy of Medical Sciences and Peking Union Medical College. Established in 1958, the company serves as the primary industrialization base for the IMM's drug discovery and development efforts, focusing on the production of innovative small molecule drugs. Its core therapeutic areas include hepatology, oncology, and cardiovascular medicine, with its flagship product, Bicyclol, being a first-in-class anti-hepatitis drug developed in China. PUMC Pharmaceutical operates advanced manufacturing facilities in Beijing that adhere to international GMP standards and exports its proprietary products to various global markets. By integrating academic research with industrial manufacturing, the company plays a vital role in translating scientific breakthroughs into clinical therapies within the Chinese healthcare sector.